| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
149,833 |
273,514 |
403,791 |
783,386 |
| Total Sell Value |
$57,803,893 |
$105,302,123 |
$145,030,198 |
$240,508,832 |
| Total People Sold |
7 |
10 |
12 |
12 |
| Total Sell Transactions |
21 |
34 |
49 |
76 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-10-20 |
4 |
AS |
$736.12 |
$644,105 |
D/D |
(875) |
2,986 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-10-20 |
4 |
OE |
$238.91 |
$209,049 |
D/D |
875 |
3,861 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-10-20 |
4 |
AS |
$736.12 |
$920,150 |
D/D |
(1,250) |
4,068 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-10-20 |
4 |
OE |
$170.76 |
$213,446 |
D/D |
1,250 |
5,318 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2020-10-20 |
4 |
AS |
$736.12 |
$1,325,016 |
D/D |
(1,800) |
7,839 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2020-10-20 |
4 |
OE |
$193.08 |
$347,544 |
D/D |
1,800 |
9,639 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-09-10 |
4 |
AS |
$718.50 |
$1,087,809 |
D/D |
(1,514) |
4,068 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-09-10 |
4 |
OE |
$170.76 |
$213,446 |
D/D |
1,250 |
5,582 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2020-08-31 |
4 |
AS |
$723.73 |
$723,730 |
D/D |
(1,000) |
4,560 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2020-08-31 |
4 |
OE |
$193.08 |
$193,080 |
D/D |
1,000 |
5,560 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2020-08-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
3,468 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-08-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
80 |
2,986 |
|
- |
|
| Rosa David J. |
EVP and Chief Business Officer |
• – – |
2020-08-05 |
4 |
AS |
$693.02 |
$11,670,416 |
D/D |
(16,840) |
26,479 |
|
- |
|
| Rosa David J. |
EVP and Chief Business Officer |
• – – |
2020-08-05 |
4 |
OE |
$113.73 |
$2,729,520 |
D/D |
24,000 |
43,319 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2020-07-27 |
4 |
AS |
$677.19 |
$5,078,930 |
D/D |
(7,500) |
14,672 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2020-07-27 |
4 |
OE |
$127.91 |
$959,325 |
D/D |
7,500 |
22,172 |
|
- |
|
| Desantis Robert |
Executive VP & GM IA&E |
• – – |
2020-07-24 |
4 |
AS |
$665.57 |
$1,197,848 |
D/D |
(1,798) |
3,348 |
|
- |
|
| Desantis Robert |
Executive VP & GM IA&E |
• – – |
2020-07-24 |
4 |
OE |
$178.39 |
$156,563 |
D/D |
765 |
3,731 |
|
- |
|
| Ladd Amy L |
Director |
– • – |
2020-07-24 |
4 |
AS |
$665.13 |
$36,582 |
D/D |
(55) |
128 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-07-24 |
4 |
AS |
$665.13 |
$589,970 |
D/D |
(887) |
3,066 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-07-24 |
4 |
OE |
$178.39 |
$163,337 |
D/D |
887 |
3,516 |
|
- |
|
| Nachtsheim Jami K |
Director |
– • – |
2020-07-21 |
4 |
AS |
$663.33 |
$13,267 |
D/D |
(20) |
1,087 |
|
- |
|
| Samath Jamie |
SVP of Finance |
• – – |
2020-07-21 |
4 |
AS |
$663.33 |
$498,824 |
D/D |
(752) |
207 |
|
- |
|
| Samath Jamie |
SVP of Finance |
• – – |
2020-07-21 |
4 |
OE |
$238.91 |
$296,986 |
D/D |
752 |
297 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2020-07-21 |
4 |
AS |
$670.71 |
$1,207,275 |
D/D |
(1,800) |
7,839 |
|
- |
|
2148 Records found
|
|
Page 20 of 86 |
|
|
5.92 (1.56%) 
